Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
Thong
K J
KJ
Lynch
P
P
Baird
D T
DT
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000139:chemically induced*
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil